Related Experiment Video
Updated: Jul 27, 2026
09:13
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
[Preeclampsia not (yet) predictable from the blood platelet count]
R Lazarov1, A Konijnenberg, J A van der Post
1Academisch Medisch Centrum, afd. Verloskunde en Gynaecologie, Amsterdam.
Nederlands Tijdschrift Voor Geneeskunde
|March 23, 1999
Summary
Platelet activation may help predict pre-eclampsia, a pregnancy complication. Research shows specific platelet markers increase before symptoms appear, but a reliable test is still needed.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Immunology
Context:
- Pre-eclampsia is a serious pregnancy complication.
- Platelet activation is implicated in pre-eclampsia pathogenesis.
- Current diagnostic methods for pre-eclampsia are limited.
Purpose:
- To investigate the role of platelet activation in pre-eclampsia.
- To explore the potential of platelet activation markers for early prediction of pre-eclampsia.
- To evaluate flow cytometry as a sensitive method for detecting platelet activation.
Summary:
- Pre-eclampsia is associated with altered platelet parameters, including reduced platelet count and increased mean platelet volume.
- Elevated plasma levels of beta-thromboglobulin and platelet factor 4 are observed in pre-eclamptic patients.
- Increased expression of platelet surface antigens like CD63 occurs during the first and second trimesters in pre-eclamptic pregnancies.
- Flow cytometry can detect these changes by using fluorescent-labelled antibodies to identify activated platelet antigens.
Impact:
- Platelet activation markers may serve as early predictors for pre-eclampsia.
- Developing a reliable platelet test could improve early diagnosis and management of pre-eclampsia.
- Further research is needed to establish a definitive platelet-based predictive test for pre-eclampsia.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:17Measurement of Blood Pressure
Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.